FLT3 and acute myeloid leukemia: As the changes caused by epigenetic mutations in the genome are frequently reversible, targeting epigenetic regulators or pathways holds important implications for therapeutic approaches in a specific subtype of AML, FLT3-ITD AML (Fig. 1) [14].